Abstract 3010: Thrombin Receptor Antagonist (TRA;SCH530348) is a Selective, Potent Inhibitor of PAR1 Activity with Predictable Pharmacokinetics

Abstract only Background: TRA-PCI was a multicenter, randomized, double-blind, placebo-controlled study demonstrating the safety of SCH 530348, a potent thrombin receptor antagonist (TRA), in patients undergoing non-urgent percutaneous coronary intervention (PCI). A secondary endpoint in a sub-study...

Full description

Bibliographic Details

Published in:	Circulation (New York, N.Y.) Vol. 116; no. suppl_16
Main Authors:	Jennings, Lisa K, Earhart, Angela, Becker, Richard C, Reyderman, Larissa, Veltri, Enrico, Harrington, Robert A
Format:	Journal Article
Language:	English
Published:	16-10-2007
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!